The Evidence Speaks Series is a recurring feature highlighting the latest in CHÉOS research. This series features summaries of select publications and is designed to keep the media and the research community up-to-date with CHÉOS’ current research results in the health outcomes field. To ensure this research is quick and easy to share, we are now providing social cards that you are free to save and use as you see fit.
The 33rd edition summarizes some of the latest research from CHÉOS Scientists, ICU strain and patient mortality, internet-based STBBI testing, and cognitive impairment in vulnerably housed youth.
Read More
The 32nd edition summarizes some of the latest research from CHÉOS Scientists, including cognitive decline after surgery, financial incentives in the ED, and treatment decision aids in MS patients.
Read More
The 31st edition summarizes some of the latest research from CHÉOS Scientists, including epinephrine and out-of-hospital cardiac arrest, kidney disease treatment, and barriers to post-procedure cardiac care.
Read More
The 30th edition summarizes some of the latest research from CHÉOS Scientists, including pediatric emergency wait times, congenital anomalies in HIV+ pregnancies, and treatment adherence in SALOME.
Read More
The 29th edition summarizes some of the latest research from CHÉOS Scientists, including patient preferences for rheumatoid arthritis prevention, a kidney disease risk-prediction tool, and sleep disturbance in adolescents.
Read More
The 28th edition summarizes some of the latest research from CHÉOS Scientists, including heart valve replacement, trends in primary care, and kidney replacement in the ICU.
Read More